UBS Group
IQMD

UBS Group’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

UBS Group’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,504
Closed -$15.5K – 11196
2022
Q4 		$15.5K Sell
1,504
-743
-33% -$7.55K ﹤0.01% 7979
2022
Q3 		$23K Buy
2,247
+150
+7% +$1.51K ﹤0.01% 7229
2022
Q2 		$21K Buy
2,097
+1,887
+899% +$18.9K ﹤0.01% 6847
2022
Q1 		$2K Buy
+210
New +$2.09K ﹤0.01% 9764

Other funds holding IQMD

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

UBS Group's IQMD Position: Q1 2023 in Review

UBS Group sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 1,504 shares — an estimated $15.5K sold.

UBS Group first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $23K in Q3 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

  • UBS Group reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 1,504 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $15.5K.
  • UBS Group first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
  • UBS Group's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $23K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.